TelyRx Holdings Inc. faced significant investor backlash as its stock dropped sharply in yesterday's trading session.
In a disappointing turn of events, TelyRx Holdings Inc. saw its stock price fall by 11.11% yesterday, closing at CA$2.40. This decline raises questions about the company's recent performance and investor confidence.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeAdvertisement
Market cap
$71.76M
52W high
$4.25
52W low
$2.00
1W change
-12.73%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 150.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+150.0% Upside
Current Price
C$2.40
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
108.9%
Annualized
90-Day Vol
102.0%
Annualized
Trend (90d)
-41.6%
Annualized drift
90d Mean
C$2.07
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.28 | C$1.57 – C$3.33 |
| 60 trading days | C$2.17 | C$1.28 – C$3.70 |
| 90 trading days | C$2.07 | C$1.08 – C$3.96 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should closely monitor TelyRx's financial health and market position, especially in light of its recent losses.
TelyRx Holdings Inc. stock fell 11.11% yesterday
The company's market cap now stands at approximately CA$71.76 million, highlighting its vulnerability in the current market environment.
Bull case
Despite the recent downturn, TelyRx has shown revenue growth in its latest quarterly results, suggesting there’s still potential for recovery.
Bear case
The significant loss yesterday reflects ongoing concerns about TelyRx's profitability and market strategy, which could deter investors.
Recent Performance Overview
Advertisement
TelyRx Holdings Inc. faced a challenging trading session yesterday, with its stock price dropping by 11.11%. This decline is concerning for investors, especially given the company's recent financial results which, despite showing revenue growth, still reflected a net loss of CA$4.7 million in the first quarter of 2026.
Market Reaction and Investor Sentiment
The significant drop in TelyRx's stock price indicates a negative market reaction, likely driven by investor concerns over the company's ability to maintain profitability. With a profit margin of -18.17% and no dividend yield, investors may be questioning the viability of their investments in the company. For more insights, check out the detailed financial results on Wealth Awesome.
Looking Ahead
As TelyRx Holdings Inc. navigates through these turbulent waters, investors will need to stay informed about any strategic changes or new developments. The company’s recent announcements, including its first quarter results, will be crucial in shaping future investor confidence. For ongoing updates, visit the TelyRx stock page.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
